- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02869867
Does the Application of Cold Decreases the Pain Associated in the Pose of a Patch of Capsaicine at High Concentration on the Carrier Patients of Localized Neuropathic Pains ? - DIDOCAP (DIDOCAP)
January 12, 2021 updated by: Centre Hospitalier Departemental Vendee
Nursing study, prospective, randomized, two-center open-label.
Patients will be randomized into two groups during their first laying Qutenza®:
- Patients receiving the laying of Qutenza® without refrigerated cushion
- Patients receiving the laying of Qutenza® associated with a refrigerated cushion
The objective of the study is to evaluate the effectiveness of the application of cold to the reduction of pain (burning) after one hour of patch installation high concentration capsaicin (Qutenza®) in patients localized neuropathic pain.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Challans, France, 85300
- CHLVO de Challans
-
La Roche sur Yon, France, 85925
- CHD Vendée de la Roche sur Yon
-
Nantes, France, 44000
- Clinique Breteche
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Major
- Do not opposing the participation in the study
- Monitoring in the case of localized neuropathic pain
- Diagnostic with neuropathic pain score ≥ 4
- Neuropathic pain conventional treatment failure of first-line
- Front advantage of laying a first patch Qutenza®
- With ability to understand the proposed study
Exclusion Criteria:
- Patch Installation on the feet, face, mucous membranes
- Eutectic mixture of local anesthetics (EMLA) Pose premedication
- Having Already received prior to the installation of a patch of Qutenza®
- Allergy to components Qutenza®
- Known and poorly stabilized hypertension
- Known cryoglobulinaemia
- Pregnant or lactating women
- Patient enjoying a measure of legal protection (guardianship, guardianship ...)
- Private Patient freedom
- No affiliation to a social security scheme.
- Refusal to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Qutenza® without refrigerated cushion
|
|
Experimental: Qutenza® with refrigerated cushion
|
refrigerated cushion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
visual analogue pain scale (burning pain)
Time Frame: after 1 hour of installation of Qutenza patch
|
visual analogue pain scale (burning pain)
|
after 1 hour of installation of Qutenza patch
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 2, 2017
Primary Completion (Actual)
December 4, 2020
Study Completion (Actual)
December 4, 2020
Study Registration Dates
First Submitted
August 12, 2016
First Submitted That Met QC Criteria
August 16, 2016
First Posted (Estimate)
August 17, 2016
Study Record Updates
Last Update Posted (Actual)
January 13, 2021
Last Update Submitted That Met QC Criteria
January 12, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHD049-16
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Localized Neuropathic Pain
-
University Hospital, Clermont-FerrandCompletedLocalized Neuropathic Pain | Allodynic SymptomsFrance
-
University Hospital, Clermont-FerrandFondation ApicilCompletedNeuropathic Traumatic Pain | Pain NRS ≥ 4 | Peripheral Neuropathic Pain | Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4France
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPostherpetic Neuralgia (PHN) | Chemotherapy Induced Neuropathic Pain | Diabetic Peripheral Neuropathic Pain (DPN) | HIV-related Neuropathic Pain (HIV)Colombia, Mexico, Ecuador, Peru, Venezuela
-
University Malaysia SarawakPersatuan Diabetes MalaysiaCompletedNeuropathic Pain, Nociceptive PainMalaysia
-
University Hospital, Clermont-FerrandRecruitingPeripheral Neuropathic PainFrance
-
Daiichi Sankyo Co., Ltd.CompletedCentral Neuropathic PainJapan, Korea, Republic of, Taiwan
-
Hospices Civils de LyonCompletedPharmacoresistant Neuropathic PainFrance
-
Yuhan CorporationCompletedPeripheral Neuropathic PainKorea, Republic of
-
University Hospital, Clermont-FerrandCompletedNeuropathic Pain RebelFrance
-
Ashwin ViswanathanBoston Scientific CorporationNot yet recruitingChronic Pain | Neuropathic Pain | Pain, NeuropathicUnited States
Clinical Trials on refrigerated cushion
-
University of MichiganJRD Enterprises LLC; Michigan Corporate Relations Network Small Company Innovation...CompletedStroke | Spinal Cord Injuries | Healthy AdultsUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
KalogonUnited States Department of Defense; EC ServiceCompleted
-
University of KansasSusan G. Komen Breast Cancer FoundationCompleted
-
Reckitt Benckiser Healthcare (UK) LimitedO4 ResearchCompleted
-
The First Hospital of QinhuangdaoCompletedTherapeutic Procedural ComplicationChina
-
Tarsus UniversityCompletedPain | Emergencies | Children, OnlyTurkey
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
Jonkoping UniversityEnrolling by invitationWheelchairs | Balance | Posture | Self-Help Devices | Sitting Position | Limits of StabilitySweden
-
VA Office of Research and DevelopmentNot yet recruitingMobility ImpairmentUnited States